Kliniske forsøg med type 1 - og type 2- diabetikere har vist nedsat postprandial hyperglykæmi med Humalog Mix25 sammenlignet med human insulin blanding 30/ 70.
Clinical trials in patients with type 1 and type 2 diabetes have demonstrated reduced postprandial hyperglycaemia with Humalog Mix25 compared to human insulin mixture 30/ 70.